Binding affinity is one of the most important determinants of protein function. Whether developing therapeutic antibodies, engineered enzymes, receptor proteins, diagnostic reagents, or synthetic biology components, improving molecular recognition can directly influence efficacy, specificity, and overall performance.
Neoncorte Bio uses artificial intelligence, computational protein engineering, and machine learning to help identify protein variants with the potential to improve binding affinity while balancing other critical properties such as stability, expression, and manufacturability.
Our computational workflows accelerate Design-Build-Test-Learn (DBTL) cycles by prioritizing promising variants before laboratory validation.